BioAdvance News

Melior Is Selected as a Top 20 CRO by Pharma Tech Outlook

By WebmasterJune 22, 2023November 1st, 2024No Comments

Melior Is Selected as a Top 20 CRO by Pharma Tech Outlook

– Melior has cover appearance on this industry-leading magazine

– Melior is recognized for the combination of its attention to quality, culture and, innovative offering

Previous PostImmunoGenesis and Cancer Focus Fund Announce $4.5 Million Investment to Support First-in-Human Trial of IMGS-001 for Relapsed or Refractory Advanced Solid Tumors
Next PostVESTECK , Inc. is excited to announce that the U.S. Patent Application No. 17/841,373 Title: REMOTE SURGICAL SUTURE SYSTEM, has been allowed by the U.S. Patent and Trademark Office (USPTO)